Superior drug fees will linger for individuals what ever the consequence of the hottest battle concerning the pharmaceutical business and health ideas over drugmaker copay support systems, analysts say. A lawsuit from drug market-backed individual advocacy teams is tough a Trump-era rule (RIN 0938-AT98) from the Facilities for Medicare & […]